Related Experiment Video

Updated: Jun 16, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Hepatitis B virus infection in children

C S O'Gorman1, K O'Connell, A M Broderick

  • 1Our Lady's Children's Hospital, Crumlin, Dublin.

Irish Medical Journal
|January 30, 2010
PubMed

Insights

Universal neonatal vaccination for Hepatitis B virus (UNV-HBV) could prevent 22% of pediatric cases and limit spread. This supports the recent introduction of UNV-HBV in Ireland.

Area of Science:

  • Pediatric Infectious Diseases
  • Hepatology
  • Public Health

Background:

  • Recent increases in Hepatitis B virus (HBV) infection necessitate understanding the pediatric landscape.
  • Characterizing HBV-infected children in Ireland is crucial for effective management and prevention strategies.

Purpose of the Study:

  • To characterize HBV-infected children in Ireland.
  • To audit the management of pediatric HBV cases.
  • To evaluate the potential impact of universal neonatal vaccination (UNV-HBV).

Main Methods:

  • Prospective data review of 46 HBV-infected children in Ireland.
  • Analysis of demographic, acquisition, HBV-DNA levels, and Hepatitis B e antigen (HBeAg) status.
  • Estimation of UNV-HBV impact on case prevention and horizontal spread.

Main Results:

  • The study included 46 children, with a median age of 8.1 years; 50% were European.
  • Vertical transmission accounted for 54.3% of cases; 62.5% had high HBV-DNA levels.
  • HBeAg was detected in 72.7% of cases.

Conclusions:

  • Universal neonatal vaccination (UNV-HBV) could have prevented an estimated 22% of identified pediatric HBV cases.
  • UNV-HBV is a key strategy to limit further horizontal HBV transmission.
  • The findings strongly support the recent implementation of UNV-HBV.

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...